NCT06684938

Brief Summary

Sacroiliac joint (SIJ) pain is one of the underappreciated causes of low back pain. Recent studies have reported excellent outcomes after Ultrasound (US) guided SIJ injection with local anesthetics and corticosteroids, but these studies are characterized by wide variability in selection criteria and patient characteristics; therefore, there is a need to determine whether any demographic or clinical variables can be used to predict US-guided SIJ injection outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable pain

Timeline
Completed

Started May 2023

Typical duration for not_applicable pain

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

October 15, 2024

Completed
28 days until next milestone

First Posted

Study publicly available on registry

November 12, 2024

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
Last Updated

November 18, 2025

Status Verified

September 1, 2024

Enrollment Period

1.6 years

First QC Date

October 15, 2024

Last Update Submit

November 15, 2025

Conditions

Pain

Outcome Measures

Primary Outcomes (2)

  • postinjection sacroiliac pain intensity

    using Visual analogue scale for pain

    3 months

  • postinjection disability questionnairre

    using Modified Oswestry disability Questionnairre

    3 months

Study Arms (1)

sacroiliac injection

EXPERIMENTAL

anaesthetic and steroid injection into the SIJ through US guidance

Drug: sacroiliac injection

Interventions

sacroiliac injectionDRUG

sacroiliac injection with local anaesthetic and corticosteroids

sacroiliac injection

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • sacroiliac pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Sherine El-Sherif

Alexandria, 21529, Egypt

Location

Alexandria University

Alexandria, Egypt

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • SHERINE EL-SHERIF

    Alexandria University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

October 15, 2024

First Posted

November 12, 2024

Study Start

May 1, 2023

Primary Completion

November 30, 2024

Study Completion

November 30, 2024

Last Updated

November 18, 2025

Record last verified: 2024-09

Locations

EG(2)